These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 373560)

  • 1. Contamination of intravenous infusion fluid: effects of changing administration sets.
    Buxton AE; Highsmith AK; Garner JS; West CM; Stamm WE; Dixon RE; McGowan JE
    Ann Intern Med; 1979 May; 90(5):764-8. PubMed ID: 373560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contamination of intravenous infusion systems--the effect of changing administration sets.
    Jakobsen CJ; Grabe N; Nielsen E; Højbjerg T; Damm M; Lorentzen K; Ersgaard HV; Villadsen J; Heebøl-Holm B; Madsen JI
    J Hosp Infect; 1986 Nov; 8(3):217-23. PubMed ID: 2878025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-use contamination of intravenous infusion fluid.
    Maki DG; Anderson RL; Shulman JA
    Appl Microbiol; 1974 Nov; 28(5):778-84. PubMed ID: 4613269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hazards of peripheral intravenous lines.
    Turnidge J
    Med J Aust; 1984 Jul; 141(1):37-40. PubMed ID: 6738409
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dressing type and change interval on intravenous therapy complication rates.
    Gantz NM; Presswood GM; Goldberg R; Doern G
    Diagn Microbiol Infect Dis; 1984 Sep; 2(4):325-32. PubMed ID: 6488748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inline filtration on postinfusion phlebitis.
    Maddox RR; John JF; Brown LL; Smith CE
    Clin Pharm; 1983; 2(1):58-61. PubMed ID: 6883931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing infection in intravenous therapy.
    Maki DG
    Hosp Pract; 1976 Apr; 11(4):95-104. PubMed ID: 829118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterobacter aerogenes primary bacteremia in pediatric patients.
    Edwards KE; Allen JR; Miller MJ; Yogev R; Hoffman PC; Klotz R; Marubio S; Burkholder E; Williams T; Davis AT
    Pediatrics; 1978 Sep; 62(3):304-6. PubMed ID: 704200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous tubing with burettes can be safely changed at 48-hour intervals.
    Gorbea HF; Snydman DR; Delaney A; Stockman J; Martin WJ
    JAMA; 1984 Apr; 251(16):2112-5. PubMed ID: 6708261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy.
    Matlow AG; Kitai I; Kirpalani H; Chapman NH; Corey M; Perlman M; Pencharz P; Jewell S; Phillips-Gordon C; Summerbell R; Ford-Jones EL
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):487-93. PubMed ID: 10432161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous catheter-associated bacteremia: role of the diagnostic microbiology laboratory.
    Crossley K; Matsen JM
    Appl Microbiol; 1973 Dec; 26(6):1006-7. PubMed ID: 4588188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of changing intravenous delivery systems at longer than 24-hour intervals.
    Band JD; Maki DG
    Ann Intern Med; 1979 Aug; 91(2):173-8. PubMed ID: 111593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective.
    Maki DG; Botticelli JT; LeRoy ML; Thielke TS
    JAMA; 1987 Oct; 258(13):1777-81. PubMed ID: 3114506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?
    Raad I; Hanna HA; Awad A; Alrahwan A; Bivins C; Khan A; Richardson D; Umphrey JL; Whimbey E; Mansour G
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):136-9. PubMed ID: 11310690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion fluids as culture media.
    Crichton EP
    Am J Clin Pathol; 1973 Feb; 59(2):199-202. PubMed ID: 4631583
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of infections from intravenous infusions.
    Med Lett Drugs Ther; 1973 Dec; 15(26):105-7. PubMed ID: 4203094
    [No Abstract]   [Full Text] [Related]  

  • 17. Microparticulate-induced phlebitis. Its prevention by in-line filtration.
    Falchuk KH; Peterson L; McNeil BJ
    N Engl J Med; 1985 Jan; 312(2):78-82. PubMed ID: 3880597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contaminated aqueous benzalkonium chloride. An unnecessary hospital infection hazard.
    Frank MJ; Schaffner W
    JAMA; 1976 Nov; 236(21):2418-9. PubMed ID: 989860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of local and systemic infection with polyethylene intravenous catheters. A prospective study of 213 catheterizations.
    Collins RN; Braun PA; Zinner SH; Kass EH
    N Engl J Med; 1968 Aug; 279(7):340-3. PubMed ID: 4969435
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing i.v. administration sets: is 48 versus 24 hours safe for neutropenic patients with cancer?
    deMoissac D; Jensen L
    Oncol Nurs Forum; 1998 Jun; 25(5):907-13. PubMed ID: 9644707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.